sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size,...

Home / Categories / Healthcare
North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
North America Injectable Drug Delivery...
Report Code
RO1/110/1362

Publish Date
01/Mar/2017

Pages
175
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The North America Injectable Drug Delivery Market is accounted to reach USD 354.53 billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others), rapidly increasing aging population and the subsequent rise in chronic conditions, rising demand of self injection devices, technological advancement and innovations in drug delivery market. .

The key market players for North America Injectable Drug Delivery Devices Market are listed below;

Pfizer and Baxter International, Inc.,
Gerresheimer AG,
Schott AG, Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Bespak, Antares Pharma,
Elcam Medical,
Haselmeier, Mylan N.V.,
Novo Nordisk,
Owen Mumford Ltd,Sanofi,
West Pharmaceutical Services, Inc,
Ypsomed Holding AG.
The market is further segmented into;
Type
Application
Usage Pattern
Mode Administration
End User
Geography

The North America injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode administration, end user, and distribution channel. The North America injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.
Injectable drug delivery device market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases and other diseases on the basis of application
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

Based on geography, the North America Injectable Drug Delivery Devices market is segmented into 11 geographical regions, such as,
U.S.,
Canada,
Mexico


Covered in this report
The report covers the present scenario and the growth prospects of the North America Injectable Drug Delivery Devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.




OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com